{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:31:13Z","timestamp":1773923473288,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00417-025-07017-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T08:14:54Z","timestamp":1768378494000},"page":"1139-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Private equity in ophthalmology: geographic trends reveal urban-rural disparities in acquisitions and satellite expansion"],"prefix":"10.1007","volume":"264","author":[{"given":"Matthew R.","family":"Heider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian E.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant D.","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-5630","authenticated-orcid":false,"given":"Matthew R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"7017_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5693\/djo.01.2022.10.004","volume":"29","author":"SA Patil","year":"2023","unstructured":"Patil SA, Vail DG, Cox JT et al (2023) Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021. Digit J Ophthalmol 29(1):1\u20138","journal-title":"Digit J Ophthalmol"},{"issue":"6","key":"7017_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1377\/hlthaff.2019.01419","volume":"39","author":"P Phelps","year":"2020","unstructured":"Phelps P, Mills T (2020) The growth of private equity investment in health care: perspectives from ophthalmology. Health Aff (Millwood) 39(6):1026\u20131031. https:\/\/doi.org\/10.1377\/hlthaff.2019.01419","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"7017_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/jamainternmed.2020.3552","volume":"180","author":"JD Bruch","year":"2020","unstructured":"Bruch JD, Gondi S, Song Z (2020) Changes in hospital income, use, and quality associated with private equity acquisition. JAMA Intern Med 180(11):1428\u20131435. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3552","journal-title":"JAMA Intern Med"},{"issue":"4","key":"7017_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ophtha.2020.01.007","volume":"127","author":"EM Chen","year":"2020","unstructured":"Chen EM, Cox JT, Begaj T et al (2020) Private equity in ophthalmology and optometry: analysis of acquisitions from 2012 through 2019 in the united States. Ophthalmology 127(4):445\u2013455. https:\/\/doi.org\/10.1016\/j.ophtha.2020.01.007","journal-title":"Ophthalmology"},{"issue":"5","key":"7017_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1377\/hlthaff.2024.01204","volume":"44","author":"Y Singh","year":"2025","unstructured":"Singh Y, Bejarano Cardenas G, Torabzadeh H, Whaley CM, Borkar D (2025) Private equity\u2013owned physician practices decreased access to retinal detachment surgery, 2014\u201322. Health Aff (Millwood) 44(5):589\u2013596. https:\/\/doi.org\/10.1377\/hlthaff.2024.01204","journal-title":"Health Aff (Millwood)"},{"key":"7017_CR6","unstructured":"PitchBook Data, Inc. PitchBook. Accessed November 30 (2024) https:\/\/pitchbook.com\/"},{"key":"7017_CR7","unstructured":"U.S. Department of Agriculture, Economic Research Service. Rural-urban commuting area codes. Accessed November 30 (2024) https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes"},{"issue":"9","key":"7017_CR8","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41433-022-02244-7","volume":"37","author":"AF Shakarchi","year":"2023","unstructured":"Shakarchi AF, Thau AM, Chan RVP, Campomanes AG (2023) Geographic and socioeconomic access disparities to phase 3 clinical trials in ophthalmology in the united States. Eye (Lond) 37(9):1822\u20131828. https:\/\/doi.org\/10.1038\/s41433-022-02244-7","journal-title":"Eye (Lond)"},{"key":"7017_CR9","unstructured":"Federal Reserve Bank of St. Louis. 10-year Treasury constant maturity rate (DGS10). Accessed November 30 (2024) https:\/\/fred.stlouisfed.org\/series\/DGS10"},{"issue":"9","key":"7017_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaophthalmol.2020.3237","volume":"138","author":"MR Starr","year":"2020","unstructured":"Starr MR, Israilevich R, Zhitnitsky M et al (2020) Practice patterns and responsiveness to simulated common ocular complaints among US ophthalmology centers during the COVID-19 pandemic. JAMA Ophthalmol 138(9):981\u2013988. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3237","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"7017_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.34172\/ijhpm.2020.67","volume":"9","author":"FM Kruse","year":"2020","unstructured":"Kruse FM, Jeurissen PPT (2020) For-profit hospitals out of business? Financial sustainability during the COVID-19 epidemic emergency response. Int J Health Policy Manag 9(10):423\u2013428. https:\/\/doi.org\/10.34172\/ijhpm.2020.67","journal-title":"Int J Health Policy Manag"},{"key":"7017_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2021.02.020","volume":"223","author":"M Makar","year":"2021","unstructured":"Makar M, Friedberg D (2021) Private equity in ophthalmology: Understanding the impact on care delivery. Am J Ophthalmol 223:1\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2021.02.020","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"7017_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07829-2","volume":"22","author":"NC Coombs","year":"2022","unstructured":"Coombs NC, Campbell DG, Caringi J (2022) A qualitative study of rural healthcare providers\u2019 views of social, cultural, and programmatic barriers to healthcare access. BMC Health Serv Res 22(1):438. https:\/\/doi.org\/10.1186\/s12913-022-07829-2","journal-title":"BMC Health Serv Res"},{"key":"7017_CR14","unstructured":"National Institute for Health Care Management (NIHCM). Geographic variation in private equity penetration across physician specialties. Published 2023. Accessed November 30 (2024) https:\/\/nihcm.org\/publications\/geographic-variation-in-private-equity-penetration-across-physician-specialties"},{"key":"7017_CR15","unstructured":"Evidence-to-Impact Collaborative. Improving rural healthcare through doctor-owned practices. Accessed November 30 (2024) https:\/\/evidence2impact.psu.edu\/resources\/improving-rural-healthcare-through-doctor-owned-practices-2\/"},{"key":"7017_CR16","unstructured":"National Conference of State Legislatures. Certificate of need state laws. Accessed November 30 (2024) https:\/\/www.ncsl.org\/health\/certificate-of-need-state-laws"},{"key":"7017_CR17","unstructured":"AARP. Coronavirus state-by-state restrictions. Published November 20 (2020) Accessed November 30, 2024. https:\/\/www.aarp.org\/politics-society\/government-elections\/info-2020\/coronavirus-state-restrictions.html"},{"key":"7017_CR18","unstructured":"National Academy for State Health Policy. States\u2019 COVID-19 public health emergency declarations. Published January 25 (2024) Accessed November 30, 2024. https:\/\/nashp.org\/state-tracker\/states-covid-19-public-health-emergency-declarations\/"},{"key":"7017_CR19","unstructured":"TPG and Blackstone team up to bid for eyecare group Bausch\u2009+\u2009Lomb. Financial Times. Accessed June 16 (2024) https:\/\/www.ft.com\/content\/52aaf972-1f3a-4017-b181-74c3a3c1e6ef"},{"issue":"12","key":"7017_CR20","doi-asserted-by":"publisher","first-page":"e201213","DOI":"10.1001\/jamahealthforum.2020.1213","volume":"1","author":"FJ Lexa","year":"2020","unstructured":"Lexa FJ (2020) Private equity\u2013backed hospital investments and the impact of the coronavirus disease 2019 (COVID-19) epidemic. JAMA Health Forum 1(12):e201213. https:\/\/doi.org\/10.1001\/jamahealthforum.2020.1213","journal-title":"JAMA Health Forum"},{"key":"7017_CR21","unstructured":"PitchBook (2024) Healthcare PE firm nabs PPM exit. PitchBook. Accessed December 23. https:\/\/pitchbook.com\/news\/articles\/healthcare-pe-firm-nabbed-ppm-exit"},{"key":"7017_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2025.0002","author":"G Bejarano","year":"2025","unstructured":"Bejarano G, Torabzadeh H, Borkar D et al (2025) Private equity acquisitions and industry payments in ophthalmology. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.0002","journal-title":"JAMA Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07017-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:37:19Z","timestamp":1773909439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07017-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7017"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07017-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The Mayo Clinic IRB approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed consent"}},{"value":"Matthew R. Heider, Tian E. Tian, April M. Lee, and Prashant D. Tailor, report no conflicts of interest. Matthew R. Starr has served on advisory boards to Abbvie, Alimera Sciences, Eyepoint pharmaceuticals, and Evolve Medical as well as a Consultant to Gyroscope Therapeutics.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}